Salesforce (CRM) announced that Novartis (NVS) has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional experiences. Building upon its existing investments with Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences and Agentforce Marketing, Novartis plans to unify engagement across marketing, sales, patient services, medical, market access, and other service stakeholders. Novartis plans to roll out Salesforce’s Agentforce 360 for Life Sciences platform globally over the next five year.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRM:
- Mizuho Names Its Top Software Winners for 2026 as Sector Momentum Builds
- Salesforce initiated with a Buy at BTIG
- AI Daily: Databricks raising $4B at $134B valuation
- Trump Trade: Office of Personnel Management launching U.S. Tech Force
- OPM launching US Tech Force to implement Trump’s ‘vision for tech leadership’